Efficacy of Prolotherapy and Hydrodilatation for Frozen Shoulder
Frozen Shoulder
About this trial
This is an interventional treatment trial for Frozen Shoulder
Eligibility Criteria
Participants diagnosed with primary FS who had experienced shoulder pain for more than 6 months and a reduction > 30° in passive ROM of the affected shoulder in at least two directions (forward flexion, abduction, or external rotation) compared with the contralateral side were evaluated for eligibility. 23 Subjects with any degree of tear or calcified tendinitis of rotator cuff tendons, previous shoulder surgery, previous intra-articular injection for the affected shoulder within 3 months of the study; or any secondary FS caused by metabolic, rheumatic, infectious arthritis, stroke, tumor, shoulder fracture/dislocation, or acute cervical radiculopathy were excluded. 23
-
Sites / Locations
- Tri-Service General HospitalRecruiting
Arms of the Study
Arm 1
Experimental
evaluation prolotherapy for frozen shoulder
This pilot study highlighted that prospective studies are required to prove its clinical application for FS and other conditions.